Korea Investment Partners is a prominent venture capital and private equity firm based in Seoul, South Korea, with over 30 years of experience in the investment sector. Founded in 1986, the firm focuses on supporting bold and innovative entrepreneurs across various industries, including biotechnology, healthcare, interactive content, media, consumer internet, financial technology, information and communication technology, digitalization, semiconductor, and industrial sectors. Korea Investment Partners has established a strong track record by investing in notable companies such as Kakao, Naver, YG Entertainment, Bodyfriend, and Didi Chuxing. The firm manages more than 20 venture and private equity funds, with total assets under management amounting to approximately $1.8 billion. In addition to its headquarters in Seoul, Korea Investment Partners has offices in Shanghai, Beijing, and Sunnyvale, allowing it to operate on a global scale.
Guhada operates an online retail platform that serves as a distribution hub for luxury goods, connecting local boutiques in Europe with domestic shopping malls and the broader luxury fashion market. The platform specializes in high-demand luxury items and contemporary fashion products, offering a diverse range of bags, clothing, shoes, and accessories for both men and women. Utilizing a blockchain-based e-commerce system, Guhada ensures the authenticity of its products while providing customers with access to genuine luxury goods at competitive prices. This innovative approach enables the company to meet the growing demand for quality fashion items in the domestic market.
ActiveOn
Series B in 2025
ActiveOn, a company specializing in cosmetic materials and microcapsules, including preservative alternatives, spares no effort to share happiness with neighbors, with the objective that happy employees generate the greatest goods.
RideFlux
Series B in 2024
RideFlux Inc. is a South Korean company specializing in the development of self-driving technology for automobiles. Founded in 2018 and headquartered in Jeju Island, RideFlux focuses on creating safe and reliable autonomous transportation services. The location serves as an ideal testing ground for their technology, offering diverse road environments and varying weather conditions, which are essential for developing effective autonomous driving software. The company aims to transform driving into a more innovative and stress-free experience, addressing the growing demand for mobility services, particularly in high-traffic tourist areas. RideFlux's offerings include autonomous driving services, remote control solutions, and high-precision mapping, all designed to enhance both safety and efficiency in transportation.
Microbiotix
Series B in 2024
MicrobiotiX specializes in developing therapeutics that leverage bacteriophages and the microbiome to address multidrug-resistant infections and autoimmune diseases. The company has created a platform that facilitates the use of safe gastrointestinal microbiota transplants, enabling the formulation of fecal microbiota transplant capsules for oral administration. This innovative approach allows for convenient and cost-effective treatment options for patients, while also focusing on the research and development of bacteriophages. By integrating these technologies, MicrobiotiX aims to improve healthcare outcomes and combat pressing medical challenges.
Bio Design Lab
Series B in 2024
Bio Design Lab is a biotechnology company focused on the development of biopharmaceutical products. It specializes in creating gene, cell, and immuno-therapies through advanced systems-level genetic and genomic design strategies. By leveraging these innovative approaches, the company aims to accelerate the production of highly effective biopharmaceuticals for the treatment of various diseases, thereby enhancing the capabilities of healthcare organizations.
Firmmit
Series B in 2024
FIRMMIT is an agricultural technology company that focuses on optimizing growth data through the secure analysis of agricultural technology information. The company aims to improve farming practices, enhance crop yields, and promote sustainability. FIRMMIT provides innovative solutions such as container farms and hydroponic systems, which enable the cultivation of crops without soil while using significantly less water than traditional farming methods. These technologies are designed to help both commercial farmers and home growers utilize resources more efficiently, ultimately maximizing production capabilities.
AIDIN ROBOTICS
Series B in 2024
AIDIN ROBOTICS is a developer of AI-driven sensors and robotic systems.
Xpanner
Series B in 2024
Xpanner is a developer of a cloud-based construction management platform that aims to enhance productivity, management efficiency, and safety within the construction industry. By integrating various construction technology products, Xpanner provides a unified solution that allows construction teams to access and manage data from multiple sources through a single point of entry. This approach fosters collaboration among stakeholders, leading to improved project outcomes and an average productivity improvement of 15%. The platform also emphasizes environmental, social, and governance (ESG) enhancements, making it a comprehensive tool for modern construction management.
Inter X
Series B in 2024
Inter X is an industrial AI and big data analysis company.
EYEQ Lab
Series B in 2024
EYEQ Lab is an engineering service company that specializes in the development and manufacturing of power semiconductors. The company aims to revolutionize the power semiconductor industry by applying its expertise and advanced technologies to various sectors. Its products cater to a range of applications, including solar cells, autonomous vehicles, high-speed battery chargers, medical equipment, and aerospace. EYEQ Lab's focus on innovation and skilled engineering enables its customers to stay at the forefront of power semiconductor technologies.
LiveIn
Series B in 2024
LiveIn is a leading online marketplace specializing in student accommodation, boasting over 20,000 listings. The company operates a real estate brokerage platform designed to assist young individuals with limited economic resources in finding affordable rental housing. LiveIn prioritizes the well-being of its clients and workers, ensuring a responsible approach to their services. The platform provides a seamless rental search experience, featuring fully furnished rooms equipped with complimentary WiFi, weekly housekeeping, and maintenance services. This enables customers to easily locate and book rental properties in their vicinity, making the process efficient and user-friendly.
Juexin Technology
Series B in 2024
Juexin Technology is an entity that designs high-speed optoelectronic chips. Its primary focus is on the development of electrical chips for high-speed optical communications.
DYNE Medical Group
Series B in 2024
DYNE Medical Group is a medical equipment manufacturer specializing in endoscopy devices and artificial intelligence solutions for urological surgery. The company focuses on developing advanced manufacturing technologies that enhance the capabilities of reusable flexible endoscopes. By employing unique optimization design and ultra-precision processing techniques, DYNE Medical Group aims to improve the effectiveness of endoscopic procedures, facilitating minimally invasive treatment options for patients. Additionally, the company is involved in creating AI-based diagnostic tools for cancer detection, positioning itself at the forefront of technological innovation in the medical field.
Orange Square
Series B in 2024
Orange Square is a fintech platform that offers prepaid cards and mobile wallets for travelers.
Getcha
Series B in 2023
Getcha operates as a comprehensive online platform for car purchasing, long-term rentals, leasing, test rides, and car consulting. The company connects buyers with sellers through a comparison shopping service, allowing consumers to access a network of dealerships and obtain multiple price quotes. This transparency in transaction pricing empowers consumers to make informed decisions while enabling sellers to concentrate on potential buyers. By streamlining the car buying and renting process, Getcha aims to enhance the overall experience for both consumers and sellers in the automotive market.
CareMedi
Series B in 2023
Caremedi is a healthcare company focused on developing innovative medical devices, particularly a wearable drug pump designed to enhance the quality of life for individuals with diabetes. The company offers a range of healthcare products, including medical equipment, nebulizers, aspirators, and massagers, allowing consumers to conveniently order these items from home. By prioritizing user-friendly solutions, Caremedi aims to improve the lifestyles of its customers through accessible and effective healthcare technology.
Levit
Series B in 2023
Mobile commerce app that allows customers to have an enjoyable and affordable shopping experience
Jenfi
Funding Round in 2023
Jenfi is a financial technology company founded by Jeffrey Liu and Justin Louie, specializing in revenue-based financing for digital-native businesses in Southeast Asia. The company offers a service known as Growth Capital as a Service (GCaaS), which provides non-dilutive capital of up to US$1,000,000 to help businesses scale their marketing, inventory, and growth initiatives. Jenfi utilizes a proprietary risk assessment engine to evaluate both the creditworthiness of businesses and their marketing growth efficiency, ensuring that financing options are flexible and customized to meet the specific needs of each client. The platform has supported hundreds of digital-native companies, including various B2B and SaaS startups. Prior to founding Jenfi, Liu and Louie successfully developed and exited the fitness subscription service GuavaPass.
S-Alpha Therapeutics
Series B in 2023
S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, founded in 2019. It focuses on researching and developing health applications and platform technologies designed to treat various diseases through digital devices. The company's product lineup includes SAT-001 for ophthalmology, SAT-002 for neurology, SAT-003 for oncology, and SAT-008 for addressing social issues. In addition to these applications, S-Alpha Therapeutics is engaged in developing therapeutic devices aimed at providing innovative treatment solutions for conditions that are challenging to address with existing medical technologies. The company strives to create a healthier and more equitable society by leveraging the intersection of biology and information technology to meet unmet medical needs.
Guhada
Series B in 2023
Guhada operates an online retail platform that serves as a distribution hub for luxury goods, connecting local boutiques in Europe with domestic shopping malls and the broader luxury fashion market. The platform specializes in high-demand luxury items and contemporary fashion products, offering a diverse range of bags, clothing, shoes, and accessories for both men and women. Utilizing a blockchain-based e-commerce system, Guhada ensures the authenticity of its products while providing customers with access to genuine luxury goods at competitive prices. This innovative approach enables the company to meet the growing demand for quality fashion items in the domestic market.
VSI
Series B in 2023
VSI specializes in developing semiconductors and networking solutions tailored for the automotive and industrial sectors. The company focuses on automotive networking technologies, producing essential components for next-generation vehicles, including autonomous models. By providing innovative semiconductor products, VSI supports car manufacturers in enhancing vehicle connectivity and functionality.
Kneader
Series B in 2022
Kneader operates an online recruitment platform designed to facilitate job matching for temporary and part-time positions. The platform allows employers to post job openings and access candidate profiles, streamlining the hiring process. Job seekers can create profiles that showcase their skills, education, and experience, enabling them to browse and apply for relevant job opportunities. By focusing on short-term employment, Kneader aims to connect employers with suitable candidates efficiently.
Innospace
Series B in 2022
Innospace is an aerospace and defense company focused on developing hybrid rocket-powered small satellite launch vehicles. The company aims to provide cost-effective, low-latency, and environmentally friendly launch services tailored for the small satellite market. By utilizing innovative hybrid rocket technology, Innospace is committed to delivering reliable solutions for satellite deployment, catering to the increasing demand for efficient access to space.
NRISE
Series B in 2022
NRISE is a company that focuses on developing software applications aimed at enhancing communication and content sharing among users. It has created various applications, including MOCI and WIPPY, that facilitate connections between individuals and enable them to share diverse types of content. Additionally, NRISE offers an application tailored for home workouts, which combines fitness with social media features, allowing users to engage with workout videos and connect with others in the fitness community. Through its innovative services, NRISE aims to enrich the social media experience and promote joyful communication.
SuperBin
Series B in 2022
SuperBin Co., founded in 2015 and based in Seongnam-si, South Korea, develops innovative waste recycling robots, notably the Nephron model. This robot employs artificial intelligence to autonomously identify, sort, collect, and process recyclable materials. SuperBin aims to promote sustainable living and the importance of recycling by incentivizing users to recycle plastics and aluminum cans with financial rewards. Through its technology, the company fosters a culture of resource circulation, encouraging communities to engage in environmentally responsible practices while benefiting economically from waste materials.
Oncobix
Series B in 2022
Oncobix is a drug development company focused on creating innovative treatments for rare and incurable diseases that are often resistant to conventional medical approaches. The company has developed a novel compound, which can be represented by a chemical formula or a salt, aimed specifically at treating challenging conditions such as lung cancer. By formulating this compound into a pharmaceutical composition, Oncobix seeks to provide patients with access to groundbreaking therapies, ultimately enhancing their quality of life and advancing medical care.
Apposter
Series B in 2022
Apposter is a Korean interactive solutions company that specializes in UI development, app development, and mobile business consultancy. The company has launched various mobile applications targeted at the enterprise market, including Fotofly, Life Valley, and Tok Song. In addition to its app development services, Apposter has created a smartwatch face platform that allows users to design and create custom watch faces quickly. The company also engages in the design, manufacture, and sale of tech accessories, offering a wide range of watches and accessories for both men and women. This diverse portfolio enables clients to craft personalized watch faces and share them with a global audience.
21gram
Series B in 2022
21gram is a provider of pet funeral services that connects pet owners with reputable companion animal funeral homes. The company offers an online platform where customers can search for funeral homes based on their location, budget, and specific service needs. In addition to facilitating bookings, 21gram provides counseling services to help pet owners navigate the emotional process of saying goodbye to their pets. By focusing on both practical arrangements and emotional support, 21gram aims to ensure that pet owners can honor their beloved companions with dignity and care.
Gitple
Series B in 2022
Gitple is a technology company that develops an interactive customer support platform, offering customer experience as a cloud service. Its platform enables businesses to integrate customer service functionality into mobile applications, facilitating collaborative responses from chatbots and agents, thereby enhancing brand image and driving sales.
Genesis Lab
Series B in 2022
Genesis Lab, Inc. specializes in developing artificial intelligence-driven behavior analysis solutions aimed at enhancing human-machine communication. The company offers a range of products, including Viewinter.ai, a non-verbal behavior analysis tool designed to help job seekers prepare for video interviews, and Genesis Drive, which monitors driver drowsiness and distractions while assessing the emotional state of both drivers and passengers to enhance interactions and services. Additionally, Genesis Lab provides the Genesis Emotion AI SDK/API, enabling various industries to integrate emotion recognition technology into their applications. The company's mobile offerings include OREO, an application that humorously analyzes emotions, age, and gender from photos, and EMO, a gaming app that allows users to express and mimic emotions through facial expressions. Founded in 2017 and headquartered in Seoul, South Korea, Genesis Lab continues to innovate in the realm of AI behavior analysis.
Genieworks
Series B in 2022
Genieworks is an innovative company focused on developing a software platform tailored for e-commerce, advertising, and online-to-offline (o2o) services. The platform uniquely integrates self-marketing capabilities, open market commerce, and on-demand car concierge services through a range of applications. This technology enables businesses to effectively engage in promotional marketing, build commerce networks, and develop smart tour technology-based solutions. By combining creative ideas with advanced technology, Genieworks aims to transform how businesses operate in the digital landscape.
Toffee Pie
Series B in 2022
Toffee Pie is a retailer of bras in different sizes. They develop bras of different sizes and shapes, enabling customers with different needs to access suitable underwear. They offer a large-cup underwear brand that researches and develops bras for big-breasted girls.
Jaranda
Series B in 2022
Jaranda Co., Ltd., headquartered in Seoul, South Korea, operates a digital platform that bridges the gap between teachers, parents, and students. The company's core business is to facilitate access to childcare and education services, addressing the challenge of information asymmetry in this sector. Jaranda's platform employs analytics to match students with suitable teachers, offers regular visit services, and provides lifecycle management, ensuring children and pre-teens receive appropriate education in a convenient manner.
Yibai Technology
Series B in 2022
Yibai Technology is a specialist in healthcare-based software-as-a-service.
Adriel
Series B in 2022
Adriel is a digital marketing platform that specializes in optimizing advertising campaigns using advanced technology, including artificial intelligence. The company enables businesses to manage all their digital marketing efforts from a centralized dashboard, streamlining communication and providing essential data for effective decision-making. With a focus on delivering a cohesive promotional message, Adriel allows users to monitor their return on ad spend (ROAS) and receive real-time insights through an alert system. This functionality helps businesses identify and capitalize on opportunities across various social media platforms, adjusting their budgets to favor higher-performing campaigns. Having collaborated with over 5,000 companies globally, Adriel caters to a diverse clientele, from small businesses to large corporations, empowering them to achieve their advertising goals with clarity and efficiency.
Rizzle AI
Series B in 2022
Rizzle AI specializes in transforming text content and podcasts into engaging videos for businesses and publishers. By leveraging advanced AI technology, Rizzle enhances storytelling with professional images and natural-sounding voices, aiming to captivate audiences and facilitate content monetization. The platform offers tools for seamless video creation, including custom thumbnails, short-form content, and interactive maps, making the storytelling process efficient and impactful. Rizzle distinguishes itself through end-to-end simplicity, allowing users to produce videos quickly without complex editing. Its partnerships with media providers ensure high-quality visuals and sound, while extensive syndication options enable broad distribution and monetization through platforms like MSN and Yahoo. Rizzle provides flexible solutions tailored to individual needs, whether through self-service or managed options, allowing businesses and creators to focus on strategy and creativity.
Dr.Diary
Series B in 2022
Dr.Diary is a company that provides a comprehensive diabetes management application aimed at helping users monitor and manage their condition effectively. Founded in 2017 and based in Seoul, South Korea, the application allows users to track their blood glucose levels, exercise routines, and food intake, while offering insights on how these factors influence their health. In addition to these features, the platform includes medicine intake reminders, monthly health reports, and daily tips on diabetes management. It also facilitates communication with friends and provides personal consultation services with healthcare professionals, enhancing the overall user experience in managing diabetes.
Pin Therapeutics
Series B in 2022
Pin Therapeutics, Inc. is a biotechnology company founded in 2017 and based in South San Francisco, California. The company specializes in developing therapeutic products that utilize protein degradation technology to target and break down disease-causing proteins. Pin Therapeutics focuses on treating immune diseases, cancer, and age-related conditions. Its drug discovery efforts include programs centered on novel molecular glue degraders and a PROTAC program, aimed at addressing specific medical needs and enhancing treatment efficacy. The company employs a diverse team of scientists and leaders with experience from global pharmaceutical and biotech firms, and it operates with a notable presence in both the United States and Korea. Pin Therapeutics is committed to advancing drug discovery through innovative screening systems and platforms that improve biological specificity for targeted protein degradation.
SemiFive
Series B in 2022
SemiFive is a processor design company based in Seongnam-si, South Korea, specializing in custom silicon solutions and RISC-V Core intellectual property. The firm is recognized for pioneering platform-based system-on-chip (SoC) design, providing configurable domain-specific architectures and pre-validated key IP pools to streamline the development process. SemiFive collaborates closely with customers to translate innovative concepts into tailored semiconductor solutions, significantly reducing costs and risks associated with chip design. With robust partnerships, particularly with Samsung Foundry, it offers comprehensive end-to-end capabilities for various applications, including consumer and industrial Internet of Things (IoT), data centers, and artificial intelligence. This integrated approach enables faster realization of custom SoCs, catering to diverse client requirements efficiently.
MORAI
Series B in 2022
MORAI Inc. is a company that specializes in developing a simulation platform to create three-dimensional virtual environments that replicate real-world road conditions for testing autonomous driving algorithms. Founded in 2018 and based in Seoul, South Korea, with an additional office in San Francisco, California, MORAI focuses on verification and validation solutions for autonomous vehicles. Its platform allows automotive companies to conduct thorough simulations, enabling engineers to test scenarios that are challenging to replicate on actual roads. This approach not only reduces the costs associated with verifying autonomous driving technology but also enhances the response capabilities of self-driving systems. Additionally, the company provides datasets to support the development of advanced algorithms.
Loadcomplete
Series B in 2022
Loadcomplete is a South Korean developer of social and mobile games, founded in December 2009. The company specializes in creating engaging games for light-core to mid-core audiences, leveraging the latest technologies to foster a social gaming environment. Notable titles in its portfolio include Tap Tap Heroes, Disco Panda, Bumping Bears, Play Kale, Trino, and Blue Heart, all available on iOS and Android platforms. Loadcomplete aims to provide enjoyable experiences for game enthusiasts through its innovative and entertaining offerings.
Hutom
Series B in 2022
Hutom operates a surgical service platform designed to enhance surgical practices through innovative digital solutions. Its platform focuses on improving diagnosis and managing patient complications by utilizing robotics and laparoscopic surgery techniques. It offers an interactive report that aids surgeons in refining their methods. The process begins with an intuitive, analytical diagnosis tailored to the patient's needs, followed by a simulated examination of the surgical procedure. This includes advanced surgical video processing, recognition, analysis, and prediction, along with the provision of 3D anatomical images and AI-driven surgical analysis reports. By integrating these technologies, Hutom enables medical professionals to address complications more effectively and improve patient outcomes.
Yeoshin
Series B in 2021
Yeoshin is a skin treatment information platform.
AIONCO KOREA
Series B in 2021
AIONCO KOREA Co., Ltd., founded in 2015 and headquartered in Seoul, South Korea, specializes in global air freight and logistics services. The company offers a range of solutions, including fulfillment services, drop shipments, and global wholesale logistics, catering primarily to cross-border eCommerce clients. AIONCO KOREA is known for its comprehensive Multi-Channel Fulfillment solutions, which streamline the supply chain for both direct-to-consumer and wholesale businesses. Their services encompass planning and implementation, warehousing, distribution logistics, and storage, ensuring efficient handling of products from pallets to elegantly packaged deliveries.
Spatial
Series B in 2021
Spatial Systems, Inc. offers an augmented workplace platform designed to enhance communication and collaboration among users. Founded in 2016 and headquartered in New York, the company enables users to conduct meetings with spatial audio and 3D telepresence, facilitating a more immersive experience. Additionally, Spatial's platform allows for the sharing and organization of various digital content, including 3D models, videos, documents, images, and websites. The focus of the company is to transform how people work by creating a collective computing environment that fosters creativity and productivity. Spatial has attracted investment from notable firms and individuals, positioning itself as a leader in the augmented reality and virtual reality space.
Triple
Series B in 2021
Triple is a travel data services startup that operates a travel booking application designed to connect travelers with the tourism industry. This application facilitates the booking of hotels and restaurants, while also offering essential information such as weather updates, currency exchange rates, directions, translation services, time difference calculations, and sightseeing recommendations. By providing these services, Triple aims to simplify the travel experience, allowing travelers to explore new destinations without the need for extensive advance planning.
OncoMyx Therapeutics
Series B in 2021
OncoMyx Therapeutics, Inc., established in 2018 and based in Phoenix, Arizona, specializes in the development of oncolytic immunotherapies. The company's core focus is the myxoma virus (MYXV), a unique oncolytic virus that targets both hematologic and solid tumors. OncoMyx's innovative approach involves a patented systemic delivery method, enabling the virus to be carried by human leukocytes to tumor cells, thereby stimulating an immune response to fight cancer.
OncoMyx Therapeutics
Series B in 2021
OncoMyx Therapeutics, Inc., established in 2018 and based in Phoenix, Arizona, specializes in the development of oncolytic immunotherapies. The company's core focus is the myxoma virus (MYXV), a unique oncolytic virus that targets both hematologic and solid tumors. OncoMyx's innovative approach involves a patented systemic delivery method, enabling the virus to be carried by human leukocytes to tumor cells, thereby stimulating an immune response to fight cancer.
PDC*line Pharma
Series B in 2021
PDC*line Pharma is a clinical-stage biotech company based in France and Belgium, focused on developing innovative active immunotherapies for cancer. The company specializes in a proprietary allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line), which are loaded with cancer-specific antigens to stimulate a robust immune response. Founded in April 2014 in Grenoble by Laurent Levy and Joel Plumas, the company emerged from a research program at the French Blood Bank that developed the PDC line from a patient with PDC leukemia. PDC*line Pharma aims to enhance cancer treatment efficacy by producing potent and scalable PDC lines that can boost antitumor responses, including the activation of neoantigens and specific cytotoxic T-cells, offering a more effective alternative to conventional vaccines.
Otus
Series B in 2021
Otus is a healthcare institute that specializes in advanced eyecare system.
ONDA
Series B in 2021
ONDA is a hospitality technology company based in Seoul, South Korea, specializing in reservation management solutions for small to mid-size hotels and guesthouses both locally and internationally. The company offers a suite of products, including ONDA Plus for reservation management, ONDA Wave for integrated scheduling, and ONDA Star, a comprehensive property management system. Additionally, ONDA Easysell serves as a hotel extranet platform to enhance distribution capabilities. With a focus on optimizing hotel operations and increasing online visibility, ONDA aggregates real-time data from over 40,000 properties and distributes it across 50 online channels, enabling hotels to expand their reach and boost bookings. The company also publishes Magazine ON, which features interviews with accommodation owners and industry insights.
Aulton New Energy
Series B in 2021
Aulton New Energy is an energy service platform that focuses on the battery swap business, including core battery swap technology research and development, commercial operation of swap stations, urban distributed energy storage, and battery life cycle management.
Immunobiome
Series B in 2021
Immunobiome focuses on developing microbiome-targeted therapeutics aimed at treating challenging conditions such as cancer, autoimmune diseases, and neurological disorders. The company leverages advanced immunology, bioinformatics, and foundational microbiome research to create innovative healthcare solutions. Their platform addresses a range of health issues, including intractable immune disorders, allergies, organ transplant rejections, and diabetes-related inflammation. By targeting the microbiome, Immunobiome seeks to provide effective treatment options for patients suffering from these complex diseases.
Sellerhub
Series B in 2021
Imagine if you are the online seller, having to sign up and upload your products to 30+ different major commerce websites to maximize your sales. Sellerhub is a web-based commerce suite of solutions where you as the seller sign up, create your online shop, upload product information ONCE then it will be transferred/synched on up to 30+ different major commerce websites at the same time and allow you to manage all their orders in a single integrated dashboard. From building your online shop front, expanding commerce channels, as well as integrating marketing/ad and fulfillment operations, Sellerhub is a one-stop solution for online sellers to manage ALL of your commerce activities in a single dashboard. Key Benefits: 1. Create and manage a beautiful, fully customizable Flagship store online. 2. Single product upload, API-transfer up to 30+ major commerce websites and begin selling simultaneously 3. Fulfillment, Dropshipping, and professional services are also available for you to choose from the full suite of solutions, either directly or through partnership program Established in 2012 with accrued GMV of 1.2 Billion USD, Sellerhub offers a full suite of solutions & services that empower online seller's selling activities, helping you grow revenue and reduce cost/time managing.
Bankware Global
Series B in 2021
Founded in 2010 and headquartered in Seoul, Korea, Bankware Global is a banking software developer that specializes in providing core banking solutions and financial software systems. The company serves a diverse clientele, including retail, corporate, private, treasury, fund administration, microfinance, and community banks, with over 100 financial institutions across seven countries in the Asia Pacific region. Notably, five digital banks in Korea, China, Japan, and Taiwan utilize Bankware Global's core banking software, highlighting the company's reputation as a leading provider in this sector. With offices in three countries, Bankware Global is recognized for its expertise in creating comprehensive financial institution products and transaction business software tailored for both domestic and international markets.
Connecting
Series B in 2021
Connecting is a company that offers a real-time voice-talk service designed to facilitate meaningful conversations between individuals. Its application enables users to specify their preferences, such as hobbies, age, region, and gender, which are then matched through an algorithm tailored to enhance user experience. By providing a platform that connects people with shared interests, Connecting aims to promote engaging dialogues and foster connections in a straightforward manner.
Kilala
Series B in 2021
Kilala has a product line of color pupils and its surrounding areas to meet the full range of needs of customers.
Eyevensys
Series B in 2021
Eyevensys S.A.S. is a Paris-based company that specializes in non-viral gene therapy for ophthalmology. Founded in 2008, it focuses on developing innovative solutions to improve drug delivery methods for ocular diseases. The company utilizes its proprietary Electro-Transfection (ET) technology to administer plasmids to the ciliary muscle, allowing for the sustained release of therapeutic proteins directly into the vitreous, addressing conditions such as uveitis, age-related macular degeneration, and various retinopathies, including central retinal vein occlusion and diabetic retinopathy. Eyevensys aims to overcome the limitations of current treatment options, which often involve invasive procedures like intravitreal injections and surgeries. By enhancing compliance, ocular bioavailability, and tolerability, Eyevensys seeks to create a robust product pipeline that delivers improved clinical outcomes while minimizing the need for frequent and invasive interventions.
Cell in Cells
Series B in 2021
Cell in Cells focuses on researching and developing cell therapy products aimed at regenerative medicine. The company utilizes advanced three-dimensional technology to differentiate stem cells, contributing to the creation of new biopharmaceuticals. By fostering innovative therapeutics, Cell in Cells supports medical professionals in treating various diseases, thereby enhancing human health through its specialized platform.
Sky Labs
Series B in 2021
Sky Labs is focused on developing innovative wearable technology for continuous health monitoring, specifically targeting atrial fibrillation, a common but often undiagnosed heart condition. The company’s flagship product, the Cardio Tracker (CART), is a cuffless, ring-type device that allows users to monitor their heart health effortlessly by simply wearing it on their finger. This device is designed to be comfortable and practical for daily use, being waterproof and dustproof so that it can be worn continuously, even during activities like showering. The CART operates without requiring user intervention, automatically detecting and recording instances of atrial fibrillation to provide users with real-time health data accessible via a smartphone app. This capability not only helps users manage their heart health but also assists healthcare professionals in diagnosing atrial fibrillation based on the data collected. Sky Labs is currently engaged in clinical trials with Seoul National University Hospital to validate the device's performance and is collaborating with Bayer to enhance its healthcare offerings. The initial target market includes atrial fibrillation patients in Finland, with a broader goal of reaching millions globally.
WonderWall
Series B in 2021
Wonderwall is an online art learning platform that connects artists and facilitates the sharing of practical knowledge. It offers a virtual learning environment where users can access a variety of online videos covering diverse subjects, including music, acting, directing, art, photography, design, and cooking. This platform enables individuals to enhance their skills and learn from experienced professionals in the comfort of their own homes.
Epibiotech
Series B in 2021
Epibiotech is a healthcare center that provides hair loss treatment solutions.
CONTEC
Series B in 2021
CONTEC is providing ground station services, satellite image processing, and application services. The company's ground station network supports VHF, UHF, S-Band, and X-Band frequencies for TT&C via high-performance receivers for high data rate reception. They especially focus on applications for urban change detection of smart cities and aim to provide the best service possible for local governments and therefore contribute to urban development. Contec's main goal of building a global ground station network and operating its own Earth observation satellites.
Modusign
Series B in 2021
Modusign is a company that specializes in electronic contract services, aimed at streamlining the contract signing process. It offers a web-based platform that allows users to sign contracts digitally, eliminating the necessity for in-person meetings. This technology helps businesses save both time and money by simplifying the contracting process, making it easier for organizations to manage their agreements efficiently.
Onul-hoi
Series B in 2021
Onul-Hoi is a mobile commerce platform specializing in the delivery of fresh fish products sourced directly from domestic fisheries. It provides customers with same-day shipping of seasonal seafood, ensuring that consumers receive high-quality products promptly. In addition to fresh fish, Onul-Hoi offers a range of seafood dishes, enhancing the convenience of meal preparation for its users. By focusing on direct sourcing and timely delivery, the platform aims to meet the growing demand for fresh, locally-sourced seafood in the market.
Trenbe
Series B in 2021
Trenbe Inc. is an e-commerce company based in Seoul, South Korea, specializing in the online sale of apparel, bags, shoes, and accessories for both men and women. Established in 2016, Trenbe has positioned itself in the footwear market while also offering a diverse range of fashion items. The company focuses on providing a convenient shopping experience for consumers through its online platform.
Hutom
Series B in 2021
Hutom operates a surgical service platform designed to enhance surgical practices through innovative digital solutions. Its platform focuses on improving diagnosis and managing patient complications by utilizing robotics and laparoscopic surgery techniques. It offers an interactive report that aids surgeons in refining their methods. The process begins with an intuitive, analytical diagnosis tailored to the patient's needs, followed by a simulated examination of the surgical procedure. This includes advanced surgical video processing, recognition, analysis, and prediction, along with the provision of 3D anatomical images and AI-driven surgical analysis reports. By integrating these technologies, Hutom enables medical professionals to address complications more effectively and improve patient outcomes.
CHAI
Series B in 2020
CHAI is a company focused on developing infrastructure technologies aimed at enhancing the efficiency of the digital economy. It offers a fintech platform that includes a debit card, a merchant-facing payment API, and an e-wallet that utilizes blockchain technology. This platform allows merchants and individual users to integrate a diverse array of payment options quickly and easily, often in less than an hour. Users can pay for items online by linking their bank accounts, streamlining the payment process. Through its innovative solutions, CHAI aims to facilitate seamless financial transactions and improve the overall digital payment landscape.
Humanscape
Series B in 2020
Humanscape, Inc. is a health-tech company based in Seoul, South Korea, that focuses on improving the treatment options for patients with rare and intractable diseases. Founded in 2016, the company utilizes blockchain technology to create a platform that collects and processes comprehensive health data, including genotype, clinical, and phenotype information. By systematically compiling this data into a ready-to-use dataset, Humanscape enables pharmaceuticals and researchers to streamline the drug development process, ultimately reducing both the time and cost associated with bringing new treatments to market. The platform aims to enhance collaboration among medical practitioners and researchers, facilitating advancements in the understanding and treatment of various incurable diseases.
MegazoneCloud
Series B in 2020
MEGAZONECLOUD, headquartered in Seoul, South Korea is established in 2018 as spun out of the cloud business of Megazone Corporation was founded in 1998 with U$45M Series-A investment. It is a customer-centric company dedicated to empowering customers with cloud-optimized technology, people and process as we believe Cloud is the optimized digital transformation platform today. They provide a broad and rich set of consulting services and technology solutions for businesses' cloud adoption and digital transformation based on a strong partnership with Amazon Web Services(AWS) and 100+global technology partners. MEGAZONE has been trusted by more than 1500 enterprise, mid-market, and SME customers, including large Korean enterprises like Samsung, LG, Lotte Group, with diverse use cases ranging from simple migration to the most complex application projects. The company's in-depth technical expertise and years of experience working with customers of different sizes and industries have proven us to be the largest premier consulting partner of AWS in Asia Pacific. Outside Korea, we currently have offices in Palo Alto, Tokyo, Shanghai, Hong Kong, and Hanoi aggressively expanding our presence in the global market.
Wave
Series B in 2020
Wave Corporation, founded in 2018 and based in South Korea, develops a mobile video chat application designed to enhance social interactions among users. The application enables individuals to create chat rooms where they can engage in group video chats, play live party games, watch video clips, read webtoons, and share photos. By facilitating these activities, Wave aims to reduce the distance between people, allowing friends to connect and interact in a more engaging and entertaining manner.
Prokarium
Series B in 2020
Prokarium Limited is a biopharmaceutical company based in London, United Kingdom, specializing in the development of vaccination and cancer immunotherapy solutions utilizing synthetic biology. The company’s product pipeline includes Vaxonella, which is designed to enhance immune responses through its unique delivery method involving micro fold cells in the small intestine. Prokarium is also working on vaccines targeting Clostridium difficile, Chlamydia trachomatis, plague, and enteric fever. With a focus on microbial immunotherapy, Prokarium aims to revolutionize cancer treatment, particularly in bladder cancer, by creating immune-driven, long-lasting antitumor effects. Founded in 2007, Prokarium is committed to advancing the field of immuno-oncology through innovative approaches that harness the power of synthetic biology.
EVOS Esports
Series B in 2020
EVOS Esports is an eSports organization focused on developing an online sports platform aimed at enhancing the eSports landscape in Southeast Asia. The company provides essential infrastructure to support professional players and content creators, fostering an environment that promotes professionalism across various competitive gaming disciplines. EVOS Esports offers a comprehensive structure for its teams, which includes in-game coaching, dedicated training facilities, and mental wellness support. This commitment to player development and well-being positions EVOS Esports as a significant player in the rapidly evolving eSports industry.
Cashkaro
Series B in 2020
Cashkaro is an Indian cashback and coupons site. They are backed by Mr. Ratan Tata and Indian VC firms, Kalaari Capital. With over two million registered users, CashKaro is a one stop destination for savings across 1500+ ecommerce sites like Amazon.in, Flipkart, Nykaa, Ajio, etc.
Gaussian Robot
Series B in 2020
Gaussian Robot, founded in 2013 and headquartered in Shanghai, China, specializes in the development of commercial automatic sweeping robots. The company offers a range of products including automatic cleaning robots, unmanned sanitation vehicles, security robot solutions, and building distribution robots. Additionally, Gaussian Robot incorporates advanced autonomous positioning navigation modules into its offerings, aiming to enhance operational efficiency in various commercial settings.
Hidden Sequence
Series B in 2020
Hidden Sequence is a production company that specializes in creating and financing drama, film, and television projects. The company focuses on producing films, telefilms, and stage dramas that feature original stories and local artists. By prioritizing freshly written narratives, Hidden Sequence aims to provide diverse content across various genres, catering to both artists and audiences.
Grip
Series B in 2020
Grip is a mobile application that offers to sell products, update stories, go online and chat communication to sellers.
G2GBIO
Series B in 2020
G2GBIO is a biotechnology company focused on improving medication administration and adherence for patients with chronic diseases. The company utilizes proprietary technology to develop advanced controlled release drug products, which aim to enhance the efficacy of medications for various chronic conditions, including diabetes and cancer. By prioritizing the needs of patients globally, G2GBIO is dedicated to providing effective treatments that facilitate better health outcomes.
eBrace
Series B in 2020
eBrace specializes in the development and manufacturing of advanced digital 3D printing technology tailored for the dental industry. The company focuses on producing bracketless invisible appliances, customized lingual invisible appliances, and dentures. Through its research and development efforts, eBrace aims to deliver precise and detailed dental products that enhance orthodontic treatments, offering innovative solutions to meet the needs of dental professionals and their patients.
Laundrygo
Series B in 2020
Laundrygo is an on-demand laundry service that offers subscription-based laundry cleaning solutions. The company focuses on delivering a convenient and efficient alternative to traditional laundry services by ensuring that customers receive their cleaned laundry within one day. By providing this rapid turnaround at a lower cost than conventional laundry shops, Laundrygo aims to enhance the customer experience and eliminate the hassle often associated with laundry tasks.
Medizen Humancare
Series B in 2020
Medizen Humancare Inc. is a research company based in Seoul, South Korea, specializing in genomic analysis for disease prediction on an individual basis. Founded in 2012, the company offers services such as M-CHECK, which assesses patients' risk for genetic diseases by analyzing genomic variations related to specific conditions. This service utilizes gene chips and analysis kits tailored for diverse populations, including Koreans and other ethnic groups. Additionally, Medizen provides MELTHY, a direct-to-consumer DNA analysis service aimed at enhancing disease prevention and promoting health longevity. The company's efforts extend across Asia, the Americas, Europe, and internationally, focusing on the acquisition of disease-specific genomic content, identifying new drug candidate genes, and developing preventive healthcare measures.
Rabbit Care
Series B in 2020
Rabbit Care is a financial services provider specializing in insurance and consulting. The company offers a diverse range of insurance products, including automotive, health, life, and corporate insurance. Through its digital platform and customer care center, Rabbit Care aims to deliver an exceptional customer experience and effectively meet the needs of its clients. By leveraging technology, the company enhances accessibility and efficiency in its service delivery, ensuring that businesses can satisfy customer expectations.
SecuLetter
Series B in 2020
SecuLetter Co Ltd is a company focused on providing advanced solutions to combat cyber threats, including malware and phishing attacks. The company employs hybrid approaches that integrate both static and dynamic analysis to detect unknown attacks, even as cyber criminals increasingly try to conceal malicious content within emails. SecuLetter specializes in diagnosing and analyzing security vulnerabilities at the assembly level, which allows for a detailed examination of non-executable files, resulting in a high detection rate for security threats and vulnerabilities. Its primary business areas encompass email security, secure data transmission between networks, web service file protection, document centralization security, cloud support security, and security threat intelligence. The company's commitment to delivering fast and accurate diagnostics positions it as a leader in the cybersecurity field.
Pharos iBio
Series B in 2020
Pharos iBio Co. is a biotechnology company focused on the development of innovative treatments for rare and intractable diseases. Leveraging a novel drug development platform that incorporates big data and artificial intelligence technology, the company aims to address significant medical needs. Among its product candidates are PHI-101-AML, targeting refractory or relapsed acute myeloid leukemia; PHI-101-OC, designed for patients with platinum-resistant or refractory ovarian cancer; and PHI-101-TNBC, aimed at treating metastatic triple-negative breast cancer. Additionally, the company is advancing several other candidates, including PHI-201, PHI-301, and PHI-501. Through its targeted approach, Pharos iBio seeks to contribute to the advancement of treatment options in oncology.
Longmao Data
Series B in 2020
Longmao Data is a Beijing-based company established in 2014 that specializes in data services for artificial intelligence platforms. The firm collects a diverse array of data types, including images, texts, voices, and videos, and employs crowdsourcing methods for data annotation. This annotated data is then supplied to clients in the artificial intelligence sector, facilitating the training of their AI models. Longmao Data's focus on comprehensive data collection and annotation positions it as a valuable partner for businesses looking to enhance their AI capabilities.
PDC*line Pharma
Series B in 2020
PDC*line Pharma is a clinical-stage biotech company based in France and Belgium, focused on developing innovative active immunotherapies for cancer. The company specializes in a proprietary allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line), which are loaded with cancer-specific antigens to stimulate a robust immune response. Founded in April 2014 in Grenoble by Laurent Levy and Joel Plumas, the company emerged from a research program at the French Blood Bank that developed the PDC line from a patient with PDC leukemia. PDC*line Pharma aims to enhance cancer treatment efficacy by producing potent and scalable PDC lines that can boost antitumor responses, including the activation of neoantigens and specific cytotoxic T-cells, offering a more effective alternative to conventional vaccines.
Funda
Series B in 2020
Funda is a P2P finance service that connects multiple investors to sound stores that need funds and creates a financial service.
HappyEasyGo
Series B in 2019
HappyEasyGo is an online travel company based in India that specializes in providing affordable air tickets and hotel accommodations. The platform allows users to book flights with various airlines, including IndiGo, Jet Airways, Go Air, SpiceJet, Air Asia, Vistara, and Air India. It offers a user-friendly interface that enables customers to search for discounted airfare and take advantage of promotional deals for advance bookings. HappyEasyGo is committed to helping travelers save on their travel expenses by providing a wide range of options and verified discounts on hotels and flights.
Norma
Series B in 2019
Norma Inc. is a computer network security company based in Korea. The firm specializes in providing consulting services focused on cyber asset security and information asset security. Through its expertise, Norma aims to help organizations safeguard their digital infrastructure and sensitive information against various cyber threats.
SecuLetter
Series B in 2019
SecuLetter Co Ltd is a company focused on providing advanced solutions to combat cyber threats, including malware and phishing attacks. The company employs hybrid approaches that integrate both static and dynamic analysis to detect unknown attacks, even as cyber criminals increasingly try to conceal malicious content within emails. SecuLetter specializes in diagnosing and analyzing security vulnerabilities at the assembly level, which allows for a detailed examination of non-executable files, resulting in a high detection rate for security threats and vulnerabilities. Its primary business areas encompass email security, secure data transmission between networks, web service file protection, document centralization security, cloud support security, and security threat intelligence. The company's commitment to delivering fast and accurate diagnostics positions it as a leader in the cybersecurity field.
Ansun Biopharma
Series B in 2019
Ansun Biopharma, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing innovative therapies to prevent and treat serious human diseases. The company specializes in host-directed anti-viral therapies, which aim to combat respiratory viral infections, including various strains of influenza and parainfluenza viruses. Its lead product candidates include Fludase, designed for the prophylaxis and treatment of respiratory infections, and Viradin, an intravenous therapeutic for sepsis and viral hemorrhagic fevers caused by pathogens such as Ebola and Marburg viruses. Additionally, Ansun Biopharma has developed TOSAP, a formulation technology for drug delivery using microspheres and nanospheres. Founded in 2003, the company was previously known as NexBio, Inc. before rebranding in 2011.
Crowdworks
Series B in 2019
CrowdWorks, Inc. is a South Korea-based company that operates an online crowdsourcing platform specifically designed for artificial intelligence (AI). The company focuses on enhancing machine learning processes by collecting, structuring, and strengthening training data. It provides services that include the analysis and classification of various types of data, such as images, text, audio, and survey responses. By utilizing a pool of approximately 500,000 qualified labelers, CrowdWorks aims to improve the accuracy of human-powered data, thereby streamlining the AI model training workflow. The platform's Auto-ML features facilitate efficient data preparation, making it an essential resource for over 430 leading AI companies seeking to rapidly develop and deploy advanced AI solutions.
HappyEasyGo
Series B in 2019
HappyEasyGo is an online travel company based in India that specializes in providing affordable air tickets and hotel accommodations. The platform allows users to book flights with various airlines, including IndiGo, Jet Airways, Go Air, SpiceJet, Air Asia, Vistara, and Air India. It offers a user-friendly interface that enables customers to search for discounted airfare and take advantage of promotional deals for advance bookings. HappyEasyGo is committed to helping travelers save on their travel expenses by providing a wide range of options and verified discounts on hotels and flights.
OncXerna Therapeutics
Series B in 2019
OncXerna Therapeutics, Inc. is a biotechnology company focused on developing precision medicines for cancer patients by utilizing an RNA-based biomarker platform. The company aims to improve patient outcomes by prospectively identifying individuals based on the unique RNA biology of their tumor microenvironments. This innovative approach enables OncXerna to match patients with targeted oncology therapies that correspond to their specific tumor characteristics. Founded in 2018 and based in Waltham, Massachusetts, with an additional location in Shanghai, China, OncXerna was formerly known as Oncologie, Inc. and changed its name in September 2020 to reflect its commitment to advancing next-generation precision medicine for a broader range of cancer patients.
Tapas Media
Series B in 2019
Tapas Media, Inc. operates Tapastic, an online platform that serves as a community for indie comic artists and visual storytellers. Founded in 2012 and based in San Francisco, the company supports over 50,000 creators who publish original serialized webcomics and novels. With more than 2 million monthly unique readers, the platform engages users for a total of 70 million minutes each month, and its stories have been read over 5 billion times. Tapas Media collaborates with top creators to co-produce original intellectual properties that can be adapted into various media formats, including television series and films. The audience predominantly consists of female millennials in the United States, and the Tapas app is among the top-grossing comics applications on both iOS and Android, with over 2 million downloads.
GlowRoad
Series B in 2019
GlowRoad is a social selling platform that focuses on providing earning opportunities for Indian women and small businesses. The mobile application facilitates online retailers and small to medium enterprises (SMEs) to earn income by promoting selected products and services within their social networks, both online and offline. The platform primarily attracts users such as housewives and graduate students, allowing them to sell goods within their communities and among friends and family. This model enables individuals to generate income from home without requiring any initial investment, thus creating a secure and accessible environment for entrepreneurship.
Hisense Bio
Series B in 2019
Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.
Triple
Series B in 2019
Triple is a travel data services startup that operates a travel booking application designed to connect travelers with the tourism industry. This application facilitates the booking of hotels and restaurants, while also offering essential information such as weather updates, currency exchange rates, directions, translation services, time difference calculations, and sightseeing recommendations. By providing these services, Triple aims to simplify the travel experience, allowing travelers to explore new destinations without the need for extensive advance planning.
Halodoc
Series B in 2019
PT HaloDoc is a digital healthcare platform based in Jakarta, Indonesia, founded in 2016. It connects patients with a network of 19,000 licensed doctors and 1,000 certified partner pharmacies through its services. Users can engage with medical professionals via video calls, voice calls, and chat, making healthcare more accessible. The platform also allows patients to order laboratory tests that can be conducted at home. Additionally, HaloDoc helps users locate the nearest hospitals and clinics, streamlining the process of obtaining medical advice and services in real-time.
PR&D Company
Series B in 2019
PR&D Company designs and develops hey dealer app and website for car-selling services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.